Medicinal Resins of Socotra: Phytochemical Diversity, Biological Activities, Safety, and Evidence Gaps
Molecules · 29.10.2026 · 31 (21) · 3904
DOI: 10.3390/molecules31213904 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 29.10.2026. Verfasst von Abeer Essam Noman und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Sciences, Shandong Xiehe University, Jinan 250109, China. Hauptthemen laut MEDLINE: Resins, Plant, Phytochemicals, Plant Extracts, Dracaena. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Socotra (Yemen) is home to several resin-producing plant groups. This review evaluates the phytochemistry, biological activities, and safety of Dracaena cinnabari, Socotran Boswellia, and Commiphora resins, identifies gaps in the available evidence, and distinguishes resin-derived findings from bark-derived evidence. D. cinnabari resin contains homoisoflavans and chalcones, but quantitative data for major phenolics remain insufficient. Resin preparations showed antifungal and radical-scavenging activity in vitro; a resin extract and two chalcone derivatives reduced hepatitis B virus antigen production in culture without establishing antiviral efficacy. A methanolic resin extract was cytotoxic to six oral squamous cell carcinoma lines (half-maximal inhibitory concentration [IC50]: 5.9–19.2 µg/mL). Two rat carcinogenesis protocols reported 14.3% carcinoma incidence at 1000 mg/kg versus 85.7% in carcinogen-only controls. A single study of acute and 28-day oral toxicity provides limited, extract-specific safety data. Boswellia and Commiphora resin chemistry is documented mainly through volatile profiles. B. elongata resin yielded 21 compounds, including boswellic acids, whose presence does not establish pharmacological equivalence to B. serrata or B. sacra; four triterpenoid acids inhibited yeast α-glucosidase (IC50 9.9–56.8 µM), but antidiabetic efficacy was not tested. Most other Boswellia bioactivity data concern bark. (+)-Yangambin accounted for 3.50–9.05% (w/w) of recovered C. ornifolia ethanol extracts. No eligible bioassays of Commiphora resins or human studies were identified. The evidence does not support therapeutic claims.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical Sciences, Shandong Xiehe University, Jinan 250109, China.
- Department of Physical Activity, Faculty of Education and Science, Rada'a, Albaydha University, Albaydha 14517, Yemen.
ORCID-Profile: Abeer Essam Noman, Naif S Al-Barha, Fuad A Abdu
Zitieren
APA
Noman, A. E., Al-Barha, N. S., & Abdu, F. A. (2026). Medicinal Resins of Socotra: Phytochemical Diversity, Biological Activities, Safety, and Evidence Gaps. Molecules, 31(21), 3904. https://doi.org/10.3390/molecules31213904
Vancouver
Noman AE, Al-Barha NS, Abdu FA. Medicinal Resins of Socotra: Phytochemical Diversity, Biological Activities, Safety, and Evidence Gaps. Molecules. 2026;31(21):3904. doi:10.3390/molecules31213904
BibTeX
@article{Noman2026,
author = {Noman, Abeer Essam and Al-Barha, Naif S and Abdu, Fuad A},
title = {Medicinal Resins of Socotra: Phytochemical Diversity, Biological Activities, Safety, and Evidence Gaps},
journal = {Molecules},
year = {2026},
volume = {31},
number = {21},
pages = {3904},
doi = {10.3390/molecules31213904}
}
EUVIMED